- AmerisourceBergen reports Q4 results
- McKesson takes majority stake in German drug distributor Celesio
- Expect more retail pharmacy operators and wholesalers to accumulate significant transglobal frequent flyer miles
- Hamacher's Dave Wendland to moderate DSN Diabetes & Chronic Care Roundtable for 10th-consecutive year
- AmerisourceBergen launches new Pharmacy Ownership Program
VALLEY FORGE, Pa. — AmerisourceBergen on Thursday elected Lon Greenberg, 62, to its board of directors, effective immediately. Greenberg fills the vacancy created by Charles Cotros’s retirement from the board in February 2013. Greenberg also joined the audit and corporate responsibility committee and finance committee of the board. AmerisourceBergen's board of directors is currently comprised of 10 directors.
“Lon’s extensive business experience, strategic vision and extraordinary commitment and dedication to our community will make Lon a great asset to the AmerisourceBergen board,” stated Richard Gozon, chairman of the board of AmerisourceBergen.
Greenberg served as CEO of UGI Corporation from 1995 until his retirement on April 1, 2013. Greenberg continues to serve as the chairman of UGI’s board of directors, a position he has held since 1996. He joined UGI in 1980 and held a number of senior management and executive positions throughout his career with UGI, including SVP legal and corporate development, and president of UGI.
In addition to serving as the chairman of UGI Corporation, Greenberg is a director of Aqua America and Ameriprise Financial. Greenberg also is a member of the board of trustees of Temple University, the board of directors of Temple University Health System, and the board of directors of Fox Chase Cancer Center. Furthermore, he currently serves as chair of the board of directors of the United Way of Greater Philadelphia and Southern New Jersey.
Get connected and follow us on LinkedIn for the most in-depth coverage of drug store news. Join the conversation.